Global Oncology Information Systems Market Industry Overview and Forecast to 2031 – Market Analysis and Market Size

Global Oncology Information Systems Market - Industry Overview

The global oncology information systems market is expanding rapidly, propelled by increasing cancer rates, advancements in technology, and a growing need for integrated solutions that enhance clinical and operational efficiency in oncology care. According to the National Cancer Institute (NCI), cancer remains a leading cause of death worldwide, with nearly 20 million new cases and 9.7 million cancer-related deaths reported in 2022. OIS encompasses a range of software tools designed to manage various aspects of cancer treatment, including electronic health records (EHRs), radiation therapy planning, and chemotherapy management. The market’s growth is fueled by rising cancer incidences and the demand for personalized treatment approaches that require advanced data management and analysis.

Data Bridge Market Research Market Report provides details of new recent developments, market share, market trends on the basis of its segmentations and regional analysis, the impact of market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.

Global Oncology Information Systems Market Size

Technological advancements, including cloud-based solutions and artificial intelligence, are significantly advancing the market by providing more accurate diagnostics and optimizing workflows. Furthermore, the use of machine learning algorithms enhances the prediction of patient outcomes and the customization of treatment plans, ultimately improving the overall quality of oncology care. As a result Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Oncology Information Systems Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 4.30 billion in 2023 and is expected to grow upto USD 7.91 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Oncology Information Systems Market Dynamics

Global Oncology Information Systems Market Growth Drivers

Increasing Prevalence of Cancer

According to National Cancer Institute by 2040, the number of new cancer cases per year is expected to rise to 29.9 million and the number of cancer-related deaths to 15.3 million.  As healthcare systems seek to manage the burgeoning volume of cancer patients and improve treatment outcomes, OIS technologies will play a crucial role in enhancing diagnostic precision, streamlining clinical workflows, and supporting personalized care approaches, thereby driving the global oncology information systems market.

Antibiotic Resistance

According to Personalized Medicine Coalition in 2020, personalized medicines accounted for 39 percent of newly approved Neuromuscular Electrical Stimulation (NMEs). The shift towards personalized medicine requires sophisticated data management and analysis tools. OIS systems are essential for tailoring treatment plans to individual patient profiles, thereby driving Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market growth Opportunities

Demand for Streamlining Patient Information

The integration of oncology information systems (OIS) with existing electronic health record (EHR) systems presents Enhanced interoperability between OIS and EHRs which can streamline data management, leading to more efficient workflows and improved patient care. This integration facilitates seamless data exchange and better coordination across healthcare platforms thus fueling Global Oncology Information Systems Market growth.

Government and healthcare initiatives

Government investment in healthcare provides a huge potential opportunity for the global oncology information systems (OIS) market. For instance, the United States government has earmarked around $11.6 billion in 2023 for healthcare IT infrastructure under the "21st Century Cures Act," which intends to improve data interoperability and promote healthcare technologies. Such investments encourage the use and development of OIS solutions. Consequently fostering the Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market growth Challenges

Complexity of System Integration

The System Integration process often requires extensive customization to align OIS with various data sources, electronic health records (EHRs), and other healthcare systems. This integration can disrupt clinical workflows and create operational challenges, as healthcare providers may face difficulties in synchronizing data, managing system compatibility, and ensuring smooth transitions from legacy systems to new technologies. Thus hindering the overall Global Oncology Information Systems Market growth.

Data Security and Privacy Concerns

Protecting sensitive patient information from unauthorized access and breaches is critical due to the increasing number of electronic health records and treatment data. Compliance with various rules, such as Australia's Privacy Act 1988, places rigorous restrictions on how personal data is handled and secured, whereas Canada's Personal Information Protection and Electronic Documents Act (PIPEDA) requires safeguards for personal health information. The high expenses of adopting and maintaining these security measures can be a significant barrier to OIS adoption. As a result, hampering the Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market Restraints

Regulatory and market approval hurdles

The complexity of meeting various regulatory standards causes delays in the approval and deployment of OIS solutions, limiting market entrance and acceptance. For instance, in the European Union, OIS vendors must follow the Medical Device Regulation (MDR), that imposes severe standards for clinical studies and post-market supervision. The regulation necessitates comprehensive paperwork and rigorous testing, which extend the approval process and raise expenses.

Global Oncology Information Systems Market Scope and Trends

• The U.S. Department of Health and Human Services (HHS), via the Office of the National Coordinator for Health Information Technology (ONC), has released the Health Data, Technology, and Interoperability (HTI-2) proposed rule. This initiative underscores ONC’s commitment to enhancing interoperability and improving information exchange among patients, healthcare providers, insurers, and public health agencies.
• New TPS platforms use artificial intelligence and machine learning algorithms to enhance treatment planning and improve dosage administration accuracy. For instance, Varian's ARIA® oncology information system includes AI-powered tools such as SmartSegmentation, which uses machine learning to automate the segmentation of tumors and surrounding tissues, improving radiation therapy planning precision and reducing the time required for manual contouring.
• Surgical oncologists from Chennai's Apollo Cancer Centre (ACC) performed India's first Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for peritoneal surface cancer. The minimally invasive, robotic-assisted method represents a paradigm shift in the treatment of Pseudomyxoma Peritonei (PMP), an aggressive appendix cancer, providing patients with a new standard of care which enables for faster recovery and better quality of life.
• Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) are becoming more advanced, allowing for highly targeted radiation delivery to tumors while minimizing damage to surrounding healthy tissues.
• C-Care and Healthcare Global Enterprises (HCG) partnered to provide cancer care services in Mauritius. HCG will offer clinical and outpatient consultation (OPD) services at the C-Care Cancer Center, which is housed within C-Care Darné in Floréal.

Global Oncology Information Systems Market Regional Analysis – Market Trends

Key Insights

• The North American market dominates the global Oncology Information Systems (OIS) market driven by high adoption of cutting-edge technologies, and the presence of major industry players. The U.S. leads the region, benefiting from substantial investments in cancer research and the increasing integration of AI in healthcare.
• Asia-Pacific region is experiencing rapid growth in the OIS market, fueled by increasing healthcare spending, rising cancer rates, and government support for digital health. Countries such as China and India are witnessing significant investments in OIS infrastructure.
• The European OIS market is experiencing steady growth, driven by factors such as increasing healthcare spending, government regulations for electronic health records (EHRs), and a growing awareness of the benefits of OIS in improving cancer care.

Global Oncology Information Systems Market Leading Players

• Koninklijke Philips N.V. (Netherlands)
• Varian Medical Systems, Inc (U.K)
• McKesson Corporation (U.S.)
• Siemens (Germany)
• Elekta (Sweden)
• Epic Systems Corporation (U.S.)
• IBM (U.S.)
• Cerner Corporation (U.S.)
• Advanced Data Systems (U.S.)
• BMSI Partners, Inc. (U.S.)
• F. Hoffmann-La Roche AG (Switzerland)
• AmerisourceBergen Corporation (U.S.)
• General Electric (U.S.)
• Accuray Incorporated (U.S.)
• OPTUM Inc., (U.S.)
• Allscripts Healthcare Solutions, Inc. (U.S.)
• MICA Information Systems, Inc. (U.S.)
• CureMD Healthcare (U.S.)
• EndoSoft LLC (U.S.)
• RaySearch Laboratories (Sweden)

Global Oncology Information Systems Market Recent Developments

• In May, 2024 RaySearch Laboratories AB announced that its oncology information system, RayCare* 2024A, has been certified for compatibility with Varian TrueBeam linear accelerators, version 3.0. RaySearch and Varian Medical Systems collaborated on testing activities throughout 2024, resulting to this accreditation.
• In April, 2024, STOCKHOLM - Elekta and MIM Software Inc, a leading provider of medical imaging management and artificial intelligence solutions acquired by GE HealthCare, announced a collaboration to combine best-in-class solutions for advanced treatment planning in radiation therapy delivery.
• In May, 2024 STOCKHOLM - Elekta has announced the release of its latest linear accelerator (linac), Evo*, a CT-Linac with new high-definition AI enhanced imaging which can deliver offline and online adaptive radiation therapy as well as better traditional image-guided radiation therapy treatments. This highly adaptable CT-Linac will allow clinicians to select the most appropriate radiation therapy technique for each patient.

SKU-56104